Date | Name | Activity | Value |
---|---|---|---|
Aug 29, 2023 | Deborah Weitzman Ceo, Pharmaceutical Segment | Sold | $602805 |
Aug 21, 2023 | Sold | $1785358 | |
Aug 17, 2023 | Sold | $288795 | |
Aug 17, 2023 | Stephen M Mason Ceo, Medical Segment | Sold | $5664578 |
Date | Firm | Activity | Value |
---|---|---|---|
Dec 31, 2023 | Bought | $202003 | |
Dec 31, 2023 | Bought | $225590 | |
Dec 31, 2023 | Bought | $226598 | |
Dec 31, 2023 | Bought | $289497 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
27,538,483 | Institution | 11.32% | 2,858,604,689 | |
23,487,407 | Institution | 9.66% | 2,438,086,796 | |
10,800,806 | Institution | 4.44% | 1,121,166,866 | |
9,976,862 | Institution | 4.10% | 1,035,638,183 | |
4,102,378 | Institution | 1.69% | 425,843,246 | |
3,931,683 | Institution | 1.62% | 408,124,422 | |
3,364,282 | Institution | 1.38% | 349,225,916 | |
2,000,000 | Institution | 0.82% | 207,608,000 | |
1,830,378 | Institution | 0.75% | 190,000,558 | |
1,797,048 | Institution | 0.74% | 186,540,771 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
23,487,407 | Institution | 9.66% | 2,438,086,796 | |
4,102,378 | Institution | 1.69% | 425,843,246 | |
1,830,378 | Institution | 0.75% | 190,000,558 | |
1,797,048 | Institution | 0.74% | 186,540,771 | |
1,538,106 | Institution | 0.63% | 159,661,555 | |
1,437,141 | Institution | 0.59% | 149,180,984 | |
1,188,558 | Institution | 0.49% | 123,377,075 | |
1,084,375 | Institution | 0.45% | 112,562,463 | |
1,031,317 | Institution | 0.42% | 107,054,830 | |
1,026,365 | Institution | 0.42% | 106,540,792 |
Holder | # of Shares | Type | % Holding | Value |
---|